Dengue Fever Management

Diagnostic Criteria

Dengue Shock Syndrome (DSS) is defined as meeting all criteria for Dengue Hemorrhagic Fever (DHF), with additional presentation of hypotension or narrow pulse pressure (≤20 mm Hg) 1
Dengue fever typically presents with high fever (39-40°C), non-specific symptoms: headache, retroorbital pain, myalgias, arthralgias, and skin rash, with complications such as encephalitis, hepatitis, and myoarthritis generally occurring during the critical phase (days 3-7 after fever onset) 2
The preferred diagnostic methods for Dengue fever include PCR testing, IgM capture ELISA, and convalescent IgG at 3 weeks, with a high level of evidence supporting these recommendations 2, 1, 3
Cross-reactivity can occur with other flavivirus antibodies, and malaria presents with detectable parasitemia in thick blood smear, while dengue is characterized by more severe thrombocytopenia, elevated transaminases, and positive specific serological tests, as noted by the CDC and WHO 2, 4

Normal saline is preferred over lactated Ringer's solution for fluid management, with the induced change in serum osmolality not exceeding 3 mOsm/kg/hour to prevent neurological complications, as recommended by clinical guidelines and the American Academy of Allergy and Clinical Immunology 5
Initial resuscitation with a crystalloid fluid bolus of 20 ml/kg as rapidly as possible, which may need to be repeated 2-3 times in profound shock, with a fluid administration rate of 5-10 ml/kg/hour, adjusted according to clinical response, and monitoring of vital signs every 15-30 minutes during rapid fluid administration, as recommended by the American Heart Association and supported by the American College of Physicians (ACP) and the American Society of Tropical Medicine and Hygiene (ASTMH) 6, 7, 3, 8
Patients with chronic kidney disease (CKD) should receive lower volumes of fluid than those with normal renal function, and the fluid administration rate should be adjusted based on clinical response, urine output, hematocrit trends, and signs of fluid overload, as recommended by clinical guidelines and the Centers for Disease Control and Prevention 5, 7

Electrolyte management is crucial, and once renal function is assured, 20-30 mEq/L potassium (2/3 KCl and 1/3 KPO4) should be added to maintenance fluids to prevent electrolyte imbalances, as suggested by the American Diabetes Association 9
Monitoring for signs of fluid overload, including dyspnea, enlarging liver, gallop rhythm, and pulmonary edema, is recommended to promptly identify and manage potential complications, as noted by the CDC and WHO 7

Patients can be discharged when they have no fever for 48 hours without antipyretics, improving clinical status, increasing platelet count, stable hematocrit, no respiratory distress, and good urine output, as recommended by the CDC, with a moderate level of evidence supporting these recommendations 3

Children require closer monitoring and are more susceptible to fluid overload, with an initial fluid bolus of 20 mL/kg recommended for children with dengue shock syndrome, and regular reassessment critical to detect deterioration or development of fluid overload at an early stage, as noted by the World Health Organization and the CDC 3, 6
Pregnant women are at higher risk of complications and require more intensive surveillance, as noted by the CDC and the World Health Organization, with a moderate level of evidence supporting these recommendations 3, 6
Older adults are at higher risk of developing severe dengue due to comorbidities and may require more aggressive management, as noted by the European Centre for Disease Prevention and Control (ECDC) and the CDC, with a moderate level of evidence supporting these recommendations 7, 3

The World Health Organization recommends implementing early warning systems for outbreaks, enhanced vector surveillance, and following standardized clinical management protocols focusing on fluid management and monitoring for warning signs in the management and prevention of dengue fever, with a high level of evidence supporting these recommendations 10
The CDC suggests developing and implementing dengue early warning systems specifically designed for the Philippines, integrating climate and meteorological factors with non-climate factors (socioeconomic variations, land use changes, urbanization), as noted by the CDC and WHO 10
The World Health Organization recommends strengthening vector-borne disease monitoring and surveillance systems, making human case data publicly available for research purposes, and synchronizing efforts across national disease surveillance systems and meteorological departments, with a high level of evidence supporting these recommendations 10